Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00984308 · ClinicalTrials.gov registry record · Phase 2
Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease
A Phase 2 study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 2
- Development phase
- 225
- Enrollment target
NCT00984308: Completed Phase 2 study, sponsored by VA Office of Research and Development.
NCT00984308 is a Phase 2 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 225 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00984308, a Phase 2 study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 225 participants
- Enrollment target
Study Summary
Sleep apnea is common among Veterans with cerebrovascular disease (stroke or transient ischemic attack \[TIA\]), leads to hypertension, and is associated with recurrent stroke and death. Although continuous positive airway pressure (CPAP) safely treats sleep apnea, few Veterans with cerebrovascular disease are diagnosed with sleep apnea or offered treatment.
Interventions
- PROCEDURE CPAP Therapy for Newly Diagnosed Obstructive Sleep Apnea (OSA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2008-12-23 |
| Est. Completion | 2011-09-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00984308
The ClinicalTrials.gov registry entry for NCT00984308 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 225 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CPAP Therapy for Newly Diagnosed Obstructive Sleep Apnea (OSA) is the first listed.
NCT00984308 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00984308 about?
NCT00984308 is a clinical study titled "Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease". Sleep apnea is common among Veterans with cerebrovascular disease (stroke or transient ischemic attack \[TIA\]), leads to hypertension, and is associated with recurrent stroke and death. Although continuous positive airway pressure (CPAP) safely treats sleep apnea, few Veterans with cerebrovascular ...
What is the current status of trial NCT00984308?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 225 participants. The study started on 2008-12-23. Estimated completion is 2011-09-30.
What interventions are being tested in trial NCT00984308?
The interventions under investigation include: CPAP Therapy for Newly Diagnosed Obstructive Sleep Apnea (OSA) (PROCEDURE).
Who is sponsoring clinical trial NCT00984308?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.